AGM
ELDN icon

Alpine Global Management’s Eledon Pharmaceuticals ELDN Stock Holding History

Alpine Global Management’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-13,471
Closed -$55.5K – 159
2024
Q4 		$55.5K Buy
+13,471
New +$53.1K 0.02% 146

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

Alpine Global Management's ELDN Position: Q1 2025 in Review

Alpine Global Management sold out of Eledon Pharmaceuticals (ELDN) in Q1 2025, closing a stake of 13,471 shares — an estimated $55.5K sold.

Alpine Global Management first reported a position in ELDN in Q4 2024 and held it in 1 quarter. The position peaked at $55.5K in Q4 2024. 83 funds tracked by Wall St. Rank hold ELDN as of Q1 2025.

  • Alpine Global Management reported no remaining Eledon Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Alpine Global Management sold 13,471 Eledon Pharmaceuticals shares in Q1 2025, an estimated $55.5K.
  • Alpine Global Management first reported a position in Eledon Pharmaceuticals in Q4 2024 and held it in 1 quarter.
  • Alpine Global Management's Eledon Pharmaceuticals position peaked at $55.5K in Q4 2024.
  • 83 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q1 2025.

Based on Alpine Global Management's 13F filing for Q1 2025, filed 15 May 2025.